Filipe Pereira awarded with the KiiLN Postdoctoral Entrepreneurship Award

The KiiLN- Keystone for Incubating Innovation in Life Sciences Network team and Icahn School of Medicine at Mount Sinai awarded Filipe Pereira, co-founder of Asgard Therapeutics, the KiiLN Postdoctoral Entrepreneurship Award. This award recognizes Filipe’s efforts in entrepreneurship addressing unmet needs in life sciences.


Asgard featured on the Pharma Industry report about ATMPs in Sweden

Advanced Therapies Medical Products (ATMPs) are considered the “drugs of the future”. These are based on gene, cell and tissue products. Sweden has the ambitious goal of becoming a leader in ATMPs and for this it is important to manage research efforts in an efficient way, facilitating the clinical translation of such innovative therapies. Within this thematic, Pharma Industry Publishing AB published a report on the development of ATMPs in Sweden, where Asgard Therapeutics was featured.

http://dp.hpublication.com/publication/f4655caf/mobile/

Filipe Pereira, Cristiana Pires and Fábio Rosa, co-founders of Asgard Therapeutics, awarded with the Lund University and Sparbanken Skåne’s prize for future innovations

Together with Sparbanken Skåne, in collaboration with the Sparbanksstiftelsen Finn, Lund University awarded Filipe Pereira, Cristiana Pires and Fábio Rosa the Lund University and Sparbanken Skåne’s prize for future innovations. The award is intended to promote and encourage the utilization of knowledge at Lund University.

https://www.lu.se/index.php/artikel/framtidens-innovationer-prisade-i-lund